期刊文献+

治疗性单克隆抗体表达载体的设计与优化策略 被引量:1

Strategy for design and optimization of expression vector for therapeutic monoclonal antibody
原文传递
导出
摘要 治疗性单克隆抗体的市场需求日益增长,因此如何分离得到高产的稳定表达细胞株及缩短研发过程成为此类研究的热点。在整个治疗性单克隆抗体的研发过程中,哺乳动物细胞表达载体的设计及其优化作为第一步就显得尤为重要。本文从基因转录水平的作用元件、作用方式、基因扩增与筛选标签及位置效应与整合位点的优化对治疗性单克隆抗体表达载体的设计与优化策略作一综述。 With the increasing needs for therapeutic monoclonal antibodies in market, the study in this field has focused on how to obtain a high yield and stable mammalian cell strain, which is mainly challenged by shortening the development process so as to obtain high yield and stable expression cell line. In the whole development process of therapeutic monoclonal antibodies, the design and optimization of mammalian cell expression vector as the first step play a particularly important role. This paper reviews the strategy for design and optimization of expression vector for therapeutic monoclonal antibody, including action element and mode at gene transcription level, label of gene amplification and screening, position effect as well as optimization of integration site.
作者 安晨 毛晓燕
出处 《中国生物制品学杂志》 CAS CSCD 2014年第4期568-573,共6页 Chinese Journal of Biologicals
关键词 单克隆抗体 哺乳动物细胞 作用元件 表达载体 优化 Monoclonal antibody Mammalian cells Function element Expression vector Optimization
  • 相关文献

参考文献32

  • 1Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian ceils [J]. Nat Biotechnol, 2004, 22 ( 11 ) : 1393-1398.
  • 2Jayapal KP, Wlaschin KF, Yap MGS, et al. Recombinant protein therapeutics from CHO cells-20 years and counting [J]. Chem Eng Prog, 2007, 103(1): 40-47.
  • 3de Boer L, Gray PP, Sunstrom NA. Enhanced productivity of G1 phase Chinese hamster ovary ceils using the GADD153 promoter [J]. Biotechnol Lett, 2004, 26( 1 ): 61-65.
  • 4Dai JW, Zhang QQ, Liu SC, et al. The combination of a synthetic promoter and a CMV promoter improves foreign gene expression efficiency in myocytes [J]. J Biotechnol, 2012, 158(3): 91-96.
  • 5Foecking MK, Hofstetter H. Powerful and versatile enhancer- promoter unit for mammalian expression vectors [J]. Gene, 1986, 45(1): 101-105.
  • 6Farrell ML, Mertz JE. Hormone response element in SV40 late promoter directly affects synthesis of early as well as late viral RNAs [J]. Virology, 2002, 297 (2): 307-318.
  • 7Chung S, Andersson T, Sonntag KC, et al. Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines [J]. Stem Cells, 2002, 20 (2): 139- 145.
  • 8Kim SY, Lee JH, Shin HS, et ol. The human elongation factor 1 alpha (EF-I alpha) first intron highly enhances expression of foreign genes from the murine eytomegalovirus promoter [J]. J Biotechnol, 2002, 93(2): 183-187.
  • 9Furth PA, St Onge L, Btiger H, et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter [J]. Proc Natl Aead Sei USA, 1994, 91(20): 9302- 9306.
  • 10Xu ZL, Mizuguchi H, Ishii-Watabe A, et al. Optimization of transcriptional regulatory elements for constructing plasmid vectors [J]. Gene, 2001, 272(1-2): 149-156.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部